Maximum tolerated dose of a new drug is evaluated in: (A) Phase 4, (B) Phase 3, (C) Phase 2, (D) Phase 1
Answer is D. Phase 1 Clinical trials is used to evaluate Maximum tolerated dose (MTD) of a new drug